logo
  

Nikola Says Nikola Tre Bev Approved By CARB As Zero-Emission Vehicle - Quick Facts

Nikola Corp. (NKLA), a global leader in zero-emissions transportation and energy infrastructure solutions, announced Thursday that its Nikola Tre battery-electric vehicle (BEV) has been deemed eligible for the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP) program by the California Air Resources Board (CARB).

With this approval, purchasers of the Nikola Tre BEV can now qualify for an incentive valued at $120,000 per truck, helping to reduce the total cost of ownership for any purchaser operating in the state of California.

The company said the HVIP approval is anticipated to help dramatically reduce greenhouse gas emissions and lowers the total cost of ownership for Nikola's California-based customers. HVIP is administered by CALSTART, a national clean transportation nonprofit consortium, on behalf of CARB.

With a range of up to 350 miles, the Nikola Tre BEV is expected to have the longest range among the current HVIP eligible Class 8 tractors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared... Richmond, Utah-based Casper's Ice Cream is recalling its 56 ounce tubs of "Red Button Vintage Creamery Canadian Vanilla Ice Cream" due to undeclared allergen, the U.S. Food and Drug Administration said. According to the agency, a limited number of the product were mispackaged with Burnt Almond Fudge Ice Cream containing undeclared almonds. Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement.
Follow RTT